Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome

Experimental and Therapeutic Medicine

Volumn 6, Issue 1, 2013, Pages 93-96

  Gao, Jingguo ^a  

^a Xingtai People's Hospital   (China)

Author keywords

Anxiety; Cytokine; Depression; IL 1 ; IL 10; Irritable bowel syndrome

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MALE; MIXED ANXIETY AND DEPRESSION; OUTCOME ASSESSMENT; RADIOIMMUNOASSAY; SELF-RATING ANXIETY SCALE; SELF-RATING DEPRESSION SCALE;

EID: 84878185746     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1101     Document Type: Article

References (24)

1. Occhipinti K and Smith JW: Irritable bowel syndrome: a review and update. Clin Colon Rectal Surg 25: 46-52, 2012.
2. Lackner JM, Gudleski GD, Dimuro J, Keefer L and Brenner DM: Psychosocial predictors of self-reported fatigue in patients with moderate to severe irritable bowel syndrome. Behav Res Ther 51: 323-331, 2013.
3. Stasi C, Rosselli M, Bellini M, Laffi G and Milani S: Altered neuro-endocrine-immune pathways in the irritable bowel syndrome: the top-down and the bottom-up model. J Gastroenterol 47: 1177-85, 2012.
4. Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ and Hutchinson IV: Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component. Gut 52: 91-93, 2003.
5. Chan J, Gonsalkorale W and Perrey M: IL-10 and TGF-beta genotype in irritable bowel syndrome: evidence to support an inflammatory component? Gastroenterology 118: A1191, 2000.
6. Longstreth GF, Thompson WG, Chey WD, Houghton LA, MearinF and Spiller RC: Functional bowel disorders. Gastroenterology 130: 1480-1419, 2006.
7. Fukudo S: Role of corticotrophin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J Gastroenterol 42: 48-51, 2007.
8. Spiller R and Campbell E: Post-infectious irritable bowel syndrome. Curr Opin Gastroenterol 22: 13-17, 2006.
9. Wouters MM and Boeckxstaens GE: Neuroimmune mechanisms in functional bowel disorders. Neth J Med 69: 55-61, 2011.
10. Camilleri M: Evolving concepts of the pathogenesis of irritable bowel syndrome: to treat the brain or the gut? J Pediatr Gastroenterol Nutr 48 (Suppl 2): S46-S48, 2009.
11. Sugaya N and Nomura S: Relationship between cognitive appraisals of symptoms and negative mood for subtypes of irritable bowel syndrome. Biopsychosoc Med 2: 9, 2008.
12. Nicholl BI, Halder SL, Macfarlane GJ, etal: Psychosocial risk markers for new onset irritable bowel syndrome-results of a large prospective population based study. Pain 137: 147-155, 2008.
13. Camilleri M and Fealy RD: Idiopathic autonomic denervation in eight patients presenting with functional gastrointestinal disease: A causal association? Dig Dis Sci 35: 609-616, 1990.
14. Schiepers OJ, Wichers MC and Maes M: Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29: 201-217, 2005.
15. Smulevich AB, Rappoport SI, Syrkin AL, etal: Visceral neuroses: clinical approaches to the problem. Zh Nevrol Psikhiatr Im S S Korsakova 102: 15-21, 2002 (In Russian).
16. Chadwick VS, Chen W, Shu D, etal: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology122: 1178-1783, 2002.
17. Li Y, Wang Y, Zuo X, etal: Visceral perception thresholds after rectal thermal and pressure stimuli in irritable bowel syndrome patients. J Gastroenterol Hepatol 19: 187-191, 2004.
18. Smart HL and Atkinson M: Abnormal vagal function in irritable bowel syndrome. Lancet 2: 475-478, 1987.
19. Dinan TG, Quigley EM, Ahmed SM, etal: Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology130: 304-311, 2006.
20. Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 130: 1377-1390, 2006.
21. Heller F, Florian P, Bojarski C, etal: Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology129: 550-564, 2005.
22. Liebregts T, Adam B, Bredack C, etal: Immune activation in patients with irritable bowel syndrome. Gastroenterology 132: 913-920, 2007.
23. Akbar A, Yiangou Y, Facer P, Walters JR, Anand P and GhoshS: Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 57: 923-929, 2008.
24. Binimelis J, Webb SM and Monés J: Somatostatin and the irritable bowel syndrome. Lancet 2: 1533, 1987